Lothar Stitz
16Patents
6h-index
13Co-inventors
63Inventor score
Filing activity: Jan 6, 1995 → Mar 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9623095B2 | Vaccination in newborns and infants | Emerging Cross-Sectional Technologies | 64 | Active |
| US10172935B2 | Vaccination in newborns and infants | Emerging Cross-Sectional Technologies | 27 | Active |
| US10596252B2 | Vaccination in newborns and infants | Emerging Cross-Sectional Technologies | 24 | Active |
| US10729761B2 | Vaccination in newborns and infants | Emerging Cross-Sectional Technologies | 24 | Active |
| US10682426B2 | Rabies vaccine | Chemistry; Metallurgy | 23 | Active |
| US11369694B2 | Rabies vaccine | Chemistry; Metallurgy | 10 | Active |
| US6077510A | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6015660A | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6113905A | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12036277B2 | Vaccination with mRNA-coded antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US8709410B2 | Anti-prion protein antibody fragment | General | 0 | Revoked |
| US12083190B2 | Rabies vaccine | Chemistry; Metallurgy | 0 | Active |
| US11672856B2 | Vaccination in newborns and infants | Emerging Cross-Sectional Technologies | 0 | Active |
| US11975064B2 | Vaccination with mRNA-coded antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US12390520B2 | Vaccination in newborns and infants | Emerging Cross-Sectional Technologies | 0 | Active |
| US8852587B2 | Anti-prion protein antibody fragment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.